Literature DB >> 1683669

Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.

K Haginoya1, K Yamamoto, K Iinuma, T Yanagisawa, Y Ichinohasama, M Shimmoto, Y Suzuki, K Tada.   

Abstract

Immunohistochemical localization of dystrophin was studied in a symptomatic carrier of Becker muscular dystrophy (BMD). Muscle biopsy specimens from a female carrier showed findings compatible with slowly progressive muscular dystrophy by ordinary histochemical examinations. Immunohistochemical study, using an antiserum raised against a synthetic peptide fragment of dystrophin, demonstrated a mixture of staining patterns, including continuous but faint positive fibres, partially disrupted fibres and negative fibres. These findings were identical to those of patients with BMD and appear to differ from previous findings in female carriers of Duchenne muscular dystrophy. This report is the first immunohistochemical study of a symptomatic female proven by molecular genetic analysis to be a carrier of BMD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683669     DOI: 10.1007/bf00319855

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  The manifesting carrier in Duchenne muscular dystrophy.

Authors:  H Moser; A E Emery
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

2.  [Biochemical, histological and clinical findings in a four-year-old female carrier of benign X-linked muscular dystrophy (Becker type)].

Authors:  H Moser
Journal:  Humangenetik       Date:  1971

3.  Unusual inheritance of Becker type muscular dystrophy.

Authors:  L Aguilar; R Lisker; G G Ramos
Journal:  J Med Genet       Date:  1978-04       Impact factor: 6.318

4.  Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.

Authors:  K Arahata; E P Hoffman; L M Kunkel; S Ishiura; T Tsukahara; T Ishihara; N Sunohara; I Nonaka; E Ozawa; H Sugita
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.

Authors:  E Bonilla; B Schmidt; C E Samitt; A F Miranda; A P Hays; A B de Oliveira; H W Chang; S Servidei; E Ricci; D S Younger
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

6.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Molecular heterogeneity of translocations associated with muscular dystrophy.

Authors:  Y Boyd; E Munro; P Ray; R Worton; T Monaco; L Kunkel; I Craig
Journal:  Clin Genet       Date:  1987-04       Impact factor: 4.438

8.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

9.  Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families.

Authors:  H Dorkins; C Junien; J L Mandel; K Wrogemann; J P Moison; M Martinez; J M Old; S Bundey; M Schwartz; N Carpenter
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Improved diagnosis of Becker muscular dystrophy by dystrophin testing.

Authors:  E P Hoffman; L M Kunkel; C Angelini; A Clarke; M Johnson; J B Harris
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910

View more
  1 in total

1.  Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains.

Authors:  Bailey Nichols; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Brain Sci       Date:  2015-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.